Peer-reviewed veterinary case report
Coughing dogs in Atlantic Canada treated for lungworm with milbemycin
By Conboy, G·Published in The Veterinary record·2004·Department of Pathology and Microbiology, Canada·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Natural infections of Crenosoma vulpis and Angiostrongylus vasorum in dogs in Atlantic Canada and their treatment with milbemycin oxime.
- Species:
- dog
Plain-English summary
A group of dogs in Atlantic Canada was diagnosed with lungworm (Crenosoma vulpis) and heartworm (Angiostrongylus vasorum) infections, showing symptoms like coughing and difficulty breathing. The dogs were treated with milbemycin oxime, a medication that effectively cleared the infections. In the case of the lungworm, all treated dogs showed improvement and stopped shedding larvae in their feces. For the heartworm, most dogs also recovered, although one dog with severe symptoms sadly did not survive. Overall, milbemycin oxime proved to be a successful treatment for these infections in dogs.
People also search for: dog coughing treatment · lungworm in dogs · heartworm in dogs · milbemycin oxime for dogs · dog breathing problems treatment
Abstract
Milbemycin oxime was used to treat dogs with natural infections of the fox lungworm, Crenosoma vulpis and the French heartworm, Angiostrongylus vasorum. Crenosomosis was identified in 42 of 202 dogs with clinical signs of coughing, dyspnoea or exercise intolerance by a Baermann analysis of faecal samples taken between October 2000 and October 2001. It occurred throughout Atlantic Canada (New Brunswick, Newfoundland, Nova Scotia and Prince Edward Island). The clinical signs resolved and shedding of larvae in faeces ceased in all 32 Crenosoma-infected dogs given a single oral dose of 0.5 mg/kg milbemycin oxime for which the results of faecal examinations were available. Angiostrongylosis was identified in 16 of the 202 dogs and was restricted to the Avalon peninsula of Newfoundland, where 67 dogs were tested. The clinical signs resolved and shedding of larvae ceased in 14 of the 16 dogs treated with four, weekly oral doses of 0.5 mg/kg milbemycin oxime. One dog with severe clinical signs died during the course of treatment and one owner failed to provide a faecal sample from their dog but reported that the clinical signs had resolved.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/15264484/